Sean Saint - 02 Jun 2025 Form 4 Insider Report for Beta Bionics, Inc. (BBNX)

Reporting relationship: President & CEO, Director
Issuer ticker: BBNX
Reported as of: 02 Jun 2025
Net transaction value: -$61,526
SEC form: 4
Accepted by SEC: 04 Jun 2025, 19:30:09 UTC
Prior SEC filing: 03 Mar 2025
Next SEC filing: 04 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Stephen Feider, Attorney-in-Fact

Key filing fact

Sean Saint filed Form 4 for Beta Bionics, Inc. (BBNX) on 04 Jun 2025.

Key facts

This page summarizes Sean Saint's Form 4 filing for Beta Bionics, Inc. (BBNX).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 04 Jun 2025, 19:30.

Change

Previous filing in this sequence was filed on 03 Mar 2025.
Current net transaction value: -$61,526.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002048593 Primary reporting owner

Saint Sean

Relationship: President & CEO, Director
Address: C/O BETA BIONICS, INC., 11 HUGHES, IRVINE
Signature: /s/ Stephen Feider, Attorney-in-Fact
Signature date: 04 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BBNX transaction

Common Stock

Sale

Transaction value: $16,057
Shares: -943
Change %: -0.87%
Price: $17.03
Shares after: 107,057
Date: 02 Jun 2025
Ownership: Direct
Footnotes: F1, F2

BBNX transaction

Common Stock

Sale

Transaction value: $39,655
Shares: -2,185
Change %: -2%
Price: $18.15
Shares after: 104,872
Date: 02 Jun 2025
Ownership: Direct
Footnotes: F1, F3

BBNX transaction

Common Stock

Sale

Transaction value: $5,813
Shares: -311
Change %: -0.3%
Price: $18.69
Shares after: 104,561
Date: 02 Jun 2025
Ownership: Direct
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.

Footnote F2

The weighted average sale price for the transaction reported was $17.028 and the range of prices were between $16.62 and $17.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Footnote F3

The weighted average sale price for the transaction reported was $18.1489 and the range of prices were between $17.62 and $18.60. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Footnote F4

The weighted average sale price for the transaction reported was $18.691 and the range of prices were between $18.69 and $18.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.